FreeStyle Libre

Don't know what you mean about the "hospital" version. The Libre Pro is now available but it does not allow one to take readings. Only the physician can get the data. I am asking about the Libre used in the EU and elsewhere. Officially "available sometime in 2017" however some of my ADC buddies say Q2 of this year. It's either wait for this or get a Dexcom. .

 

Some "buddy" you are. Your friends are so reliable that you would try to confirm what they told you by writing the question on the stall door in the men's bath room at the down-town bus station, and then check back for answers?

Since you are on this site, then you are either a phrama rep or employee. You therefor know the FDA site anyone can go to and get the status of new products.

 

Gee, you are one happy guy. Had a tough childhood I imagine.

 

Why don't you believe your ADC friends? Is it just a hunch, or is there some history? I'm curious because you are suggesting ADC reps are lacking in credibility. That's a big concern, because if someone like you has a even a slight doubt, then someone with higher intellect, like a doctor, NP, or pharmacist, will see right through them.

 

How is this product doing? I read about it in some journals. Is Abbott making any money on this?

 

Libre just got approval in Canada:

http://abbott.mediaroom.com/2017-06-29-Abbott-Secures-Health-Canada-License-for-FreeStyle-R-Libre-System-for-People-with-Diabetes

FDA approval just around the corner.

 

Libre is everywhere:

Abbott FreeStyle Libre – New data, but no US FDA update
New data on Abbott’s FreeStyle Libre (real-time) 14-day sensor was shared at ADA, increasing confidence in the lower-cost glucose sensor that doesn’t require any fingerstick calibration (see our previous test drive). In the US, FreeStyle Libre remains under FDA review following a submission nearly one year ago; Abbott has not shared a recent update on approval expectations. This device was recently approved in Canada and Mexico and is now available in 35+ countries. It currently has 300,000+ global users.

FreeStyle Libre showed significant benefits for kids and teens. In the trial (aptly named “the SELFY study”), 76 pediatric FreeStyle Libre users (ages 4-17) saw an average increase of one hour per day spent in-range, while experiencing an average A1c drop of 0.4%.

In a real-world study of over 55,000 adult users on FreeStyle Libre in Europe, more frequent “scanning” of the on-body sensor (to check a real-time glucose value) was associated with lower A1cs, less time in hypoglycemia (under 70 mg/dl), more time-in-range (70-180 mg/dl), and less time in hyperglycemia (over 180 mg/dl). Without the hassle of fingersticks, some people checked their glucose up to 50 times per day by scanning the sensor! Consistent with other studies, FreeStyle Libre users took just a few fingersticks per week to confirm the sensor readings, but otherwise used FreeStyle Libre for dosing insulin and making diabetes decisions.

We also saw data on FreeStyle Libre Pro from a study in India at ADA. At multiple study sites, use of FreeStyle Libre Pro drove an average decline in A1c of 1.0%, compared to a 0.7% drop in the control group. The “Pro” version is a blinded, non-real-time system that healthcare providers use. The sensor is placed on the arm of a person with diabetes in the office, and two weeks later, a provider-owned reader device downloads all 14 days’ worth of continuous glucose data (no fingersticks needed during wear, no devices to carry around). This Pro version is currently available in the US – see this diaTribe piece for more details.

 

Submit an application to "Early Family Member Product Release Group". Your chances of getting the Freestyle Libre early are about 75/25 in your favor. Plus it would be free with signing a waiver. Good luck!

 

Well we did it. Libre is now FDA approved and in many countries. Over 400,000 users. This all started with the Navigator work and was much improved upon by other teams.

Hats off to all at ADC who made it happen. Great team effort. This product has changed diabetes management.

From across the Pond.

LibreMan

 

Here is a good summary:

https://diatribe.org/abbotts-freestyle-libre-approved-us-replace-routine-fingersticks

Looks like a fully CGM (with Bigfoot) is coming next year.

 

AMEN!! We are totally pumped in the US to Libre!!!!!!!

 

ADC will make $1B on this puppy by 2020 in the US alone. Bye Bye DexCom....

 

more like $2 billion!!!!

 

Now users can us an iPhone to read the Libre. Cool product.

http://abbott.mediaroom.com/2018-02-07-Abbotts-App-for-FreeStyle-R-Libre-System-Now-Available-in-Europe-for-Both-iPhone-TM-and-Android-TM

 

Another solution for lazieness.

 

Best product on market!

 

With no coverage.

 

How are the US sales?

I have seen it advertised on the web. Heard a radio add and a friend said he caught the tail end of a TV add. Seems Abbott is making the effort to expose the product to the public.

 

Funny how the discussion on this thread went. Was always an argument about "how good is Libre".

Given that the product has over 500K users and generates about $420M/yr in revenue I think this would qualify as a success.